Pacer Advisors’s Harmony Biosciences HRMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.92M Buy
318,527
+28,174
+10% +$924K 0.03% 467
2025
Q4
$10.9M Sell
290,353
-72,595
-20% -$2.39M 0.03% 475
2025
Q3
$10M Sell
362,948
-17,207
-5% -$593K 0.03% 478
2025
Q2
$12M Sell
380,155
-116,804
-24% -$3.76M 0.03% 436
2025
Q1
$16.5M Sell
496,959
-1,782,959
-78% -$63.9M 0.04% 347
2024
Q4
$78.5M Buy
2,279,918
+351,582
+18% +$12.1M 0.17% 142
2024
Q3
$77.1M Sell
1,928,336
-581,273
-23% -$20.4M 0.16% 155
2024
Q2
$75.7M Buy
2,509,609
+14,695
+0.6% +$442K 0.17% 151
2024
Q1
$83.8M Buy
2,494,914
+1,270,004
+104% +$40.8M 0.19% 134
2023
Q4
$39.6M Buy
1,224,910
+1,224,681
+534,795% +$34.2M 0.11% 202
2023
Q3
$7.5K Sell
229
-436,476
-100% -$15.2M ﹤0.01% 2581
2023
Q2
$15.4M Buy
+436,705
New +$15.1M 0.06% 281

Other funds holding HRMY